Alexza Pharmaceuticals Inc. Business Finance Contracts & Agreements
33 Contracts & Agreements
- Indenture Agreements (2 contracts)
- Loan Agreements (1)
- Note Agreements (8)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Repurchase Agreements (3)
- Stock Agreements (11)
- Underwriting Agreements (1)
- Warrant Agreements (4)
- AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on June 24, 2016)
- AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN ALEXZA PHARMACEUTICALS, INC. AND TEVA PHARMACEUTICALS USA, INC. Dated as of February 23, 2016 1 (Filed With SEC on May 13, 2016)
- ALEXZA PHARMACEUTICALS, INC. STOCK ISSUANCE AGREEMENT (Filed With SEC on May 13, 2016)
- AMENDED AND RESTATED PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on May 13, 2016)
- AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on May 10, 2016)
- PROMISSORY NOTE (Filed With SEC on April 15, 2016)
- PROMISSORY NOTE (Filed With SEC on March 24, 2016)
- ALEXZA PHARMACEUTICALS, INC. STOCK ISSUANCE AGREEMENT (Filed With SEC on September 28, 2015)
- PROMISSORY NOTE (Filed With SEC on September 28, 2015)
- AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on August 6, 2015)
- ALEXZA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on March 13, 2015)
- AMENDED AND RESTATED PURCHASE OPTION AGREEMENT by and among ALEXZAPHARMACEUTICALS, INC., SYMPHONY ALLEGRO HOLDINGS LLC and SYMPHONY ALLEGRO,INC. Dated as of June 15, 2009 TABLE OF... (Filed With SEC on November 5, 2014)
- INDENTURE dated as ofMarch 18, 2014 by and between ATLAS U.S. ROYALTY, LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK... (Filed With SEC on November 5, 2014)
- ALEXZA PHARMACEUTICALS, INC. WARRANT dated as ofMarch 18, 2014 (Filed With SEC on May 5, 2014)
- INDENTURE dated as ofMarch 18, 2014 by and between ATLAS U.S. ROYALTY, LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK... (Filed With SEC on May 5, 2014)
- ALEXZA PHARMACEUTICALS, INC. 2005 NON-EMPLOYEE DIRECTORS STOCK OPTIONPLAN ADOPTED: DECEMBER 7, 2005 APPROVED BY STOCKHOLDERS: FEBRUARY 13, 2006 AMENDED: SEPTEMBER 23, 2010... (Filed With SEC on November 6, 2013)
- CONVERTIBLE PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on August 14, 2013)
- ALEXZA PHARMACEUTICALS, INC. 2005 NON-EMPLOYEE DIRECTORS STOCK OPTIONPLAN (Filed With SEC on May 22, 2013)
- COMMON STOCK PURCHASE AGREEMENT DATED AS OF JULY 20, 2012 BY AND BETWEEN ALEXZA PHARMACEUTICALS, INC. AND AZIMUTH OPPORTUNITY, L.P. TABLE OF CONTENTS (Filed With SEC on July 23, 2012)
- AMENDMENT NO.2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2012)
- ALEXZA PHARMACEUTICALS, INC. WARRANT dated as of February , 2012 (Filed With SEC on February 17, 2012)
- Alexza Pharmaceuticals, Inc. Common Stock and Warrants Underwriting Agreement dated February 17, 2012 JMP SECURITIES LLC (Filed With SEC on February 17, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 3, 2011)
- Alexza Pharmaceuticals, Inc. ID: 77-0567768Notice of Grant of Stock Options 2091 Stierlin Courtand Option Agreement Mountain View, CA 94043 [Name] Option Number: [Number][Address]... (Filed With SEC on February 22, 2011)
- Name and Title Stock Option AwardsThomas B. King President and Chief Executive Officer 213,143James V. Cassella, Ph.D. Senior Vice President, Research and Development... (Filed With SEC on February 22, 2011)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on May 26, 2010)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2008)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 26, 2008)
- STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 26, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
- ALEXZA PHARMACEUTICALS, INC. (a Delaware corporation) 6,000,000 Shares of Common Stock PURCHASE AGREEMENT (Filed With SEC on April 27, 2007)
